Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × nintedanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 3 Radiation Pneumonitis 2 Peritoneal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophagogastric Adenocarcinoma 1 Endometrial Adenocarcinoma 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Appendiceal Neoplasms 1

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡